Febuxostat, a potential drug in the secondary prevention of cardiovascular disease with hyperuricemia
- PMID: 36306952
- DOI: 10.1016/j.ijcard.2022.10.149
Febuxostat, a potential drug in the secondary prevention of cardiovascular disease with hyperuricemia
Conflict of interest statement
Declaration of Competing Interest None.
Comment on
-
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.Int J Cardiol. 2022 Feb 15;349:127-133. doi: 10.1016/j.ijcard.2021.11.076. Epub 2021 Dec 3. Int J Cardiol. 2022. PMID: 34864084 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical